Experimental research in humans and animals points to the importance of adverse respiratory effects from short-term particle exposures and to the importance of proinflammatory effects of air pollutants, pcularly 03. However, partide averaging time has not been subjected to direct scientific evaluation, and there is a lack of epidemiological research examining both this issue and whether modification of air pollutant effcs occurs with differences in asthma severity and anti-inflammatory medication use. The present study exmined the relationship of adverse asthma syptoms (bothersome or interfered with daily activities or sleep) to 03 and partides <10 Pm (PM10) in a Southern Califoria community in the air inversion zone (1200-2100 fi) with high 03 and low PM (R = 0.3). A panel of 25 asthmatics 9-17 years of age were followed daily, August through October 1995 (n -1,759 person-days exduding one subject without symptoms). Exposures inlduded stationary outdoor hourly PM0 (highest 24-hr mean, 54 plWm3, versus median of 1-hr maximums, 56 pg/m3) and 03 (mean of 1-hr maximums, 90 ppb, 5 days >120 ppb). Longitudinal regression analyses utlized the generized estimating equations (GEE) model controlling for autocorrelation, day of week, outdoor fingi, and weather. Asthma symptoms were significantly associated with both outdoor 03 and PM10 in single pollutant-and coregressions, with 1-hr and 8-hr maximum PM10 having larger effects than the 24-hr mean.
pr0.05). The largest effects were in 7 IS children not on anti-inflammatory medications [5-day, 8-hr PM1O, 9 .66 (CI, 2.80-33.21); current day, 1-hr 03, 4.14 (CI, 1.71-11.85)]. Results suggest that examination of short-term partide excursions, medication use, and symptom severity in longitudinal studies of asthma yields sensitive measures ofadverse respiratory effects ofair pollution. Key work asthma, epidemiology, longitudinal data analysis, ozone, panel study, particulate air pollution. Environ Health Perspet 106:751-761 (1998). [Online 22 October 1998] http:llehpnetl.niebs.nib.gvv/docs/)998/106p751-76ldefino/abstract.tml Recent experimental findings in humans indicate adverse respiratory effects from short-term exposures to particulate air pollutants delivered over 1 to several hours (1) . Therefore, it is biologically plausible that short-term excursions of particulate air pollution in communities could have adverse impacts on the respiratory health of susceptible individuals. However, in the experimental work to date, averaging time has not been subjected to direct scientific evaluation. For example, it is not known whether, for any given partide type, a greater or lesser effect on respiratory outcomes would occur for equivalent delivered doses given over shorter times (1 to several hours) as compared with longer times such as 24 hr (current EPA averaging time for regulatory monitoring). Also, there is a lack of epidemiological research examining respiratory effects from peak partide exposures since most have relied on daylong averaging times, namely 24 -hr means or occasionally 12-hr diurnal means. It has been suggested that the epidemiologic findings showing adverse effects of particulate matter <10 pm (PM1O) levels below the current U.S. National Ambient Air Quality Standards (NAAQS) could be partly explained by unmeasured short-term particle excursions that are captured somewhat by 24-hr averages (4. In fact, prior to recent EPA regulatory proposals for tightening the NAAQS for PM and 03, the EPA's Clean Air Science Advisory Committee advised the EPA to give a scientific rationale for the 24- hr PM1O averaging time in the NAAQS (3).
To our knowledge, there are no epidemiologic studies reported in the peer-reviewed literature that have analyzed respiratory effects ofpeak partide concentrations.
The current controversy over the EPA's regulatory changes center on the argument that improved standards are needed to protect the most susceptible subgroups in the U.S. population such as asthmatics. A recent review of the epidemiologic literature on PM and asthma suggests that mean levels of PM in North America and Europe, often within the previous NAAQS, may be responsible for increases of 2-5% in asthma hospital admissions and 5-10% in asthma emergency room (ER) visits (4) . Supporting experimental data for asthma exacerbations from PM are largely indirect, but suggest that partide deposition in the lower respiratory tract can cause inflammation, diminished mucociliary clearance and macrophage function, and adverse changes in lung function (5) . The role of 03 in airway inflammation is more clearly supported by experimental evidence showing greater increases in 03-induced inflammatory markers in bronchoalveolar lavage (BAL) fluid in asthmatics than in normal subjects (6) . Such an effect has been hypothesized to enhance allergeninduced bronchoconstriction in asthmatics (7) . Clearly, there is a scientific need for explanations of epidemiologic findings of adverse effects on asthmatics by both PM and 03 at low ambient concentrations.
Because asthmatics differ greatly with respect to disease severity, which is to a large extent dependent on the magnitude of underlying pulmonary inflammation, the proinflammatory effects of air pollutants will likely vary in more versus less severe asthmatics. Air pollutant effects may also differ depending on whether an asthmatic is taking anti-inflammatory medications, including inhaled corticosteroids, which are now considered to be the most effective front-line therapy for recurrent chronic asthma (8) . Therefore, reported effects of pollutants on asthmatic populations in epidemiologic studies may underestimate effect magnitudes in particularly susceptible subgroups.
The objective of this study is to examine the relationships of daily asthma severity to 1-hr maximum and 8-hr maximum PMIO and 03, and 24-hr mean PMIo among 24 nonsmoking pediatric asthmatics living in nonsmoking households. Outdoor concentrations of PM1O were measured with a tapered-element oscillating microbalance (TEOM; Rupprecht and Patashnick, Inc., Albany, NY), an inertial instrument that measures particle mass in real time (9) . The strength of association will be compared between 1) the different averaging times; 2) subjects having varying magnitudes of asthma symptom severity during follow-up; and 3) asthmatics taking and not taking antiinflammatory medications. Comparisons 2 and 3 aim to identify potentially susceptible subgroups of asthmatics.
Materials and Methods
Research design. The present investigation is a panel study, a longitudinal study characterized by repeated measurements of health outcomes and exposures in individuals. Whittemore and Korn (10) originally adapted the panel study for a study that showed acute adverse associations of 03 and particulate air pollution with asthma attacks in a Los Angeles, California, cohort followed in the 1970s. The present study examines the relationship of daily diary reports of asthma symptom severity to airborne environmental risk factors measured at a central outdoor site in Alpine, California, from 1 August to 30 October 1995.
The panel design makes it possible to determine the temporality of associations (i.e., the putative cause precedes the outcome) and to observe individual patterns of change in exposure and response (11 (15, 18, 19) . However, the present analysis focuses on air pollutants, and total fungal partides will be used as a control variable for air pollutant effects following an examination of fungi-pollutant interactions. Our previous analyses of asthma and outdoor fungi have been extensive, involving numerous fungal types, and stratified by the allergic sensitization of subjects (15) . Therefore, we will present such detailed analyses on this cohort in a later report.
A local brush fire occurred during the last 3 days when the TEOM sampler was malfunctioning (27) (28) (29) . Regression analysis including an indicator variable for this event showed no association with asthma symptoms and no confounding of 03 models. Possible reasons for no associations include the limited statistical power of modeling this relatively brief event and reports from subjects and their parents that outdoor activity was restricted by choice, which may have diminished smoke exposure. Models were also tested for confounding by day of week trends, temperature, relative humidity, and wind speed. Confounding was indicated by at least a 15% change in the parameter estimate for the pollutant. The analysis of wind speed was intended to examine the possible importance of wind-blown dust to particle effects. Deviance statistics for GEE models were used to assess the fit of various models. Comparisons of the fit of single versus co-pollutant models for 03 were initially restricted to days with nonmissing PMIO.
Results
Subject characteristics. Most subjects were white, non-Hispanic except for four Hispanics, one African American, and one Asian. This distribution reflects the racial/ethnic make-up of the Alpine community. Table  1 shows the characteristics of the asthmatic subjects by the groups analyzed. Eight subjects were using daily inhaled anti-inflammatory medications (six subjects were on corticosteroids, one on cromolyn and one on nedocromil). Only one pediatric MS asthmatic was on an anti-inflammatory medication (nedocromil), leaving insufficient power to make a comparison of anti-inflammatory users versus nonusers. Seven asthmatics on anti-inflammatory medications were LS asthmatics, suggesting that some of the LS asthmatics had less frequent symptoms because of their treatment regimen. The medicated LS subjects had a similar average symptom score but used more as-needed ,-agonists and were younger. The one LS subject with all binary symptom values = 0 was a 14-year-old white male taking virtually no medication during the study (not shown in Table 1 (15, 19 Regression analysis. For the GEE analysis, the magnitude of effect is expressed as the odds of asthma symptoms for a 90th percentile increase in the pollutant from its minimum level. In the analysis of the whole group of 24 subjects, asthma symptoms were significantly associated with both PM1O and 03 ( (15) . There was no confounding of PM1O or 0 effects by minimum or average relative humidity, which were not associated with symptoms. Symptoms were not significantly associated with wind speed using any averaging time, and wind did not confound PM1O or 0 effects. Parameter estimates were actua?ly negative for asthma symptoms and wind speed. Associations with PMIO variables were also stronger and significant in these 4 subjects. We then examined symptom-pollutant relationships in pediatric LS asthmatics who were on regularly scheduled doses of antiinflammatory medications (seven subjects) versus those who were not (seven subjects). Five of the subjects taking anti-inflammatory medications were on inhaled corticosteroids and two were on cromolyn. Table 6 shows the results of separate regression models for the two LS asthmatic groups. A dramatic difference emerged, suggesting effect modification by anti-inflammatory medications for both PM and 03. Findings for single pollutant models are as follows. Positive associations are shown with current day 8-hr and 24-hr PMIO in both groups, but ORs In the co-pollutant models presented in "The asthma symptom severity score was dichotomized to no symptoms or symptoms not bothersome versus symptoms bothersome or interfering with daily activities. bLess symptomatic asthmatics were defined as having <20% of days with asthma symptoms that were bothersome or interfered with daily activities during follow-up. cValues shows are pg/m3 except where indicated. dSingle pollutant models involve 71 days for PM10 and 91 days for 03 models. Co-pollutant models are for 71 days with nonmissing PM1O data; therefore, single pollutant 03 models are not strictly comparable. There was no confounding by weather or day-of-week trends.
"This includes seven subjects, five on inhaled corticosteroids and two on cromolyn, with 533 person-days of 03 observations and 424 persondays of PM10 observations. 'This includes seven subjects with 519 person-days of 03 observations and 414 person-days of PM10 observations. CAll PM15 models adjustfor current day 1-hr maximum 03; all 03 models adjustfor current day 24-hr PM10. *p<0.05; **p<O.Ol; #p0.001.
reduced by 27-29% and standard errors (SEs) are inflated (only 24-hr PMIO is still significant). There is a similar finding for the 5-day average PM1O variables, but they remain significant. Also, for subjects not on anti-inflammatory medications, current day 03 is not significant in co-pollutant models (controlling for current day 24-hr PM10), but the ORs are similar to single pollutant 03 models. Again, the regression with 03 alone was rerun, restricted to the 71 days. One-hour 03 showed a somewhat higher OR (4.65) than the co-pollutant model (3.93), although it was also not signfficant (p<0.07). A similar difference was found for the effect of 8-hr 03 in a 71-day model (OR = 3.68; p<O.1 1) compared with the co-pollutant model (OR = 3.00). The restriction to fewer days, therefore, partly explains a lack of statistical significance in the co-regression. The effect of current day 1-hr 03 was also retested by co-regressing with the 5-day average of 8-hr PM1O and the OR for 03 increased (4.24;p<o.1).
There was no confounding of PM1O or 03 effects by day ofweek, maximum temperature, or minimum or average relative humidity for either of the two groups (on or not on anti-inflammatory medications). There were no effects of wind speed using any averaging time on symptoms in either group (all p-values >0.4). An interaction term for 03 and PM1O did not improve the fit of the above models (deviance difference <2.0).
Again, the robustness of the above models in the two groups was retested accounting for fungal particles. For LS asthmatic children taking anti-inflammatory medication, there was no effect of fungi (p>0.6). In contrast, there were significant effects of fungi on asthmatic children not taking antiinflammatory medication. For an increase from the minimum to 90th percentile of fungi (see Table 2 ), the OR for the prior 24-hr average fungi was 1.70 (CI, 1.03-2.78), and the OR for the prior 12-hr daytime fungi was 1.61 (CI, 1 Cromolyn and nedocromil have different mechanisms of action and are less potent and effective anti-inflammatory medications than inhaled corticosteroids (8) . Therefore, models were retested dropping the two LS asthmatics on these medications and retaining five subjects on inhaled corticosteroids. The only change was a decrease in the effect of current day 24-hr PM1O and a loss of significance (OR = 2.12; CI, 0.53-8.44). Remaining models showed no pollutant association as in models including the seven on any anti-inflammatory medication.
To test the linearity of associations for all of the above analyses, higher pollutant days were dropped and models were retested. For 03, 5 days with over 120 ppb 1-hr maximum (the previous NAAQS) and the same 5 days with over 100 ppb 8-hr maximum were dropped and models were retested. This was repeated dropping the highest 10% of days (110 ppb 1-hr maximum and 90 ppb 8-hr maximum) and dropping the 25 days over the new 8-hr standard of 80 ppb 03. Associations disappeared below the 120 ppb threshold in the models induding the whole group and in MS asthmatic models (p>0.4), but 03 was still associated with symptoms below 120 ppb in the four sensitive MS asthmatics (ORs = 2.57-3.77), but not below 100 ppb. Effects were also found at lower 03 levels for LS asthmatics, with effect magnitudes that were relatively unchanged (days <110 ppb maximum 03, OR = 2.54; CI, 0.93-6.94). Although dropping 25 days with over 80 ppb 8-hr maximum led to a nonsignificant parameter estimate (p<0.14), the slope was still positive (OR = 4.20). Lower concentration effects were also evident in LS asthmatics not on anti-inflammatory medications, including the model excluding days with over 80 ppb 8- (20) (21) (22) (23) (24) (25) (26) . Panel studies focusing on adult asthmatics have also found adverse effects of air pollution on daily asthma severity (27) (28) (29) . Multiday moving averages of PM1O had greater effects than single day expressions in the studies examining such variables, which is consistent with the present findings. The present study adds to previous findings because it is the first to report particle effects from 1-hr and 8-hr maximum PM10 as compared with the standard metric of24-hr means. We also show informative differences in the strength of symptom-pollutant associations between groups of asthmatics stratified on their level of daily asthma symptom frequency and on anti-inflammatory medication use. Outdoor fungal particles were also significantly associated with asthma symptoms, but did not confound effects of either PMIO or 03, which is consistent with our previous studies (15, 18 low mass concentrations (e.g., the ultrafine particle fraction, polycyclic organic compounds, metals, etc.). The relevant particle toxicities (in this region at least) appear to be largely independent of 03, suggesting an important role in partide effects by primary combustion products, which in Southern California are primarily from automobile exhaust.
Effects of Ozone
The findings of the present study support the view that asthmatics may be a group particularly sensitive to the adverse respiratory effects of trophospheric 03 (31) . Recent evidence suggests that a major mechanism for this may be the effect of 03 on airway inflammation (6) , in addition to less notable effects on acute lung function responses, possibly neurally mediated (32) . This evidence was found in an experimental chamber study of 18 asthmatic and 81 normal adult subjects exposed to 197 ppb 03 over 4 hr, with 50 min/hr of treadmill exercise (6) . There were no differences between the groups in the significant 03-induced deficits in forced expiratory volume in The finding that subjects on antiinflammatory medications showed no effect of 0 is countered somewhat by another epidemiologic study (37) . In that recent study of 166 asthmatic children attending one of three week-long asthma summer camps, 71% regularly used inhaled anti-inflammatory medications. There was a significantly increased risk of an asthma exacerbation (RR = 1.4) and of experiencing chest symptoms (RR = 1.4) on the highest pollution day (03, 160 ppb) versus the average day (03, 84 ppb). Higher 03 levels were found in that study, with the previous NAAQS of 120 ppb 1-hr 03 being exceeded on 25% of the study days, versus only 5% in the present study.
The effects of 03 in the LS but not MS asthmatic group are informative. The relative lack of 03 effects in models induding all 10 pediatric MS asthmatics is unexpected because only one of these subjects was taking an anti-inflammatory medication. However, when a model was tested induding the 4 Because the maximum day's 24-hr PM1O was only 42 pg/m3, it is extremely unlikely that the new PM2 5 standard was ever exceeded during the study period. This means that partide effects may be determined by factors not entirely dependent on mass and/or that setting standards based on 24-hr averages will miss important short-term excursions during peak exposure periods. This could further explain the lack of particle effects on symptoms in the 1994 study (15) because we did not examine peak PM1O.
The EPA is also tightening the NAAQS for 03 to an 80 ppb 8-hr maximum daily concentration from the previous 120 ppb 1-hr standard. Therefore, it is of current relevance that in this study the 1-hr maximum 03 showed slightly stronger effects than the 8-hr averaging time. Findings may differ when accounting for outdoor activity profiles because the maximal exposure in the afternoon is also the time of highest hourly 03 levels. Although the 8-hr average was slightly less informative in this analysis, the effects found suggest that the new NAAQS would probably afford better protection of the susceptible asthmatic population than the current one. The reason is that the previous NAAQS of 120 ppb 1-hr maximum 03 was only exceeded 5 times, whereas the new NAAQS of 80 ppb 8-hr maximum 03 was exceeded 25 times.
Implications for Future Research
A key strength of the present findings is that the measure of asthma symptom severity we use accounts for some aspects of daily wellbeing as assessed by the individual. Additional research should incorporate similar approaches to asthma outcome assessment. The present finding of major differences in air pollution effects between asthmatics with less versus more frequent asthma symptom episodes during follow-up is directly dependent on the symptom scoring approach. The dassification Volume 106, Number 1 1, November 1998 * Environmental Health Perspectives is also based on daily longitudinal data, which is expected to yield a more accurate description of an individual's asthma severity than historical questionnaire data.
The design of the present study made it possible to find informative differences in air pollutant effects on small subgroups of asthmatic children. As discussed above, the repeated measures design can yield powerful analyses with large sample sizes (person-days) for small numbers ofsubjects. The limitation with smaller numbers of subjects is that it is more difficult to generalize results to asthmatics as a group or to asthmatics with the characteristics of the subpopulations presented herein. To this end, larger panel studies are needed in diverse populations to examine the types of host susceptibility suggested by the present subgroup analyses. Additional work is also needed to quantify asthma severity according to symptom reports (e.g., repeated spirometry). For instance, some asthmatics appear to be poor perceivers of bronchoconstriction, particularly those with chronic airflow obstruction (39) , while others may over-report symptom severity.
The results presented support the hypothesis that current day hourly peak PM1O, as well as multiple-day cumulative average exposures using 8-hr PM10 maximums, may be more informative in explaining observations of adverse partide effects on acute asthma severity than current or multiple-day 24-hr average PM10 exposures. It is possible, for instance, that outdoor peaks in PMIO are better surrogates for personal outdoor exposures during the daytime, exposures that can often occur at times of high physical activity leading to greater particle doses. Confirmation of this will require research incorporating real time PM sampling and personal particle exposure assessments. In addition, relative effects of PM1O and 03 may differ in subgroups of asthmatics depending on their current disease severity. For example, it is expected from experimental data that particle deposition and retention is greater in the airways of more severe as compared with milder asthmatics (40) . As evidenced in this paper, acute responses to the delivered dose are likely to be further modified by antiinflammatory medication use. Additional evidence for the biological plausibility and consistency of the associations presented here is expected to advance understanding of the determinants of susceptibility to adverse effects of air pollutants, induding short-duration exposure to high particle excursions.
